GSK's two predecessor companies, SmithKline Beecham and Glaxo Wellcome, which merged to form GSK in 2000, had been among the first to invest in gene-hunting technology that scientists once thought would fast lead to a bushelful of new drugs.
The only way for Sodexho to grow, Bellon thought, was to plant the company flag as fast as possible in countries where U.S. companies hadn't yet set foot.